News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News NICE rejects Amgen's Kyprolis in multiple myeloma NICE rejects drug despite efficacy and quality of life evidence.
News New Breakthrough status for Darzalex in earlier myeloma trea... Janssen's drug looking to gain bigger share in crowded myeloma market
News Janssen's Darzalex approved for myeloma in Europe Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.
News BMS and AbbVie’s myeloma drug Empliciti gains approval Multiple myeloma, one of the fastest-moving therapy areas, has just added another new treatment following FDA approval of Bristol-Myers Squibb's (BMS) and AbbVie's Empliciti (elotuzumab).
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
